NeoAdjuvant Theranostic Lutetium Study: The Nautilus Trial

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
To learn if the proposed dose of 177Lu rhPSMA-10.1 is safe. Phase 2 will open if the Phase 1 dose is found to be safe. To learn about the safety and effects of 177Lu rhPSMA-10.1 alone and with androgen deprivation therapy (ADT) on patients with high-risk, localized prostate cancer before they have surgery to remove the disease.
Epistemonikos ID: 4ab44023e851597fcd2f3a91427ca4a8862705af
First added on: May 15, 2024